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I. Introduction
According to Edd Dumbill from O’Really Media, “Big data is data that exceeds the processing capacity of conventional database 
systems. The data is too big, moves too fast, or doesn’t fit the structures 
of your database architectures. To gain value from this data, you must 
choose an alternative way to process it” [1]. The challenge is not about 
dealing with trillions of bytes of streaming data, it is about getting 
started with a quantitative approach so that you can drive value from 
your data, whatever size that data is. Data Scientists help understand 
the value of data to take timely and relevant actions [2]. 
Our economy depends on data. Data is everywhere, in every sector, 
in every country. We generate and consume data. Our interaction with 
machines, people, companies and public institutions produces data. 
Information allows us to improve the business processes and provide 
our customers and partners with the best quality standards, services 
and products. Big Data generates value in several ways, according to 
McKinsey [3]: 
• Creating transparency: making data accessible timely manner.
•  Enabling experimentation: collecting more accurate and detailed 
performance data, setting up controlling experiments. 
• Segmenting populations to customize actions, target promotions 
and advertisement. 
• Replacing/supporting human decisions making with automated 
algorithms. 
• Innovating new business models, products and services: UBER, 
Spotify, LinkedIn, Twitter, Netflix are well-known examples of this. 
Big Data is affecting healthcare too. In 2012, worldwide health care 
data reached 500 petabytes and it is expected that in 2020 there will be 
more than 25000 petabytes available. The 2011 report by McKinsey 
Global Institute estimate that the potential value that can be extracted 
from data in the healthcare sector in US could be more than $300 
billion per year.
Again, in the US, several initiatives encouraging the use of Big Data 
for health, like the Affordable Care Act, a set of health data initiatives 
by the department of health and human services. The Heritage Provider 
Network Health Prize (http://www.heritagehealthprize.com) challenge 
offers a $3 millions prize to improve healthcare avoiding unnecessary 
hospital admissions. More than 71 million individuals in the United 
States are admitted to hospitals each year, which approximately implies 
a $30 billion bill wasted, according to a survey from the American 
Hospital Association. Medicare penalizes hospitals that have high rates 
of readmissions among patients with hearth failure, hearth attack and 
pneumonia, to avoid this loss. 
US Government holds other projects like BRAIN (Brain Research 
through Advancing Innovative Neurotechnologies), bolding $100 
million to revolutionize our understanding of the human brain (that 
generates a huge amount of information). The scientists’ goal is to 
get answers to Alzheimer’s disease, epilepsy and new treatments for 
traumatic brain injury. In March 2012, the Obama Administration 
launched a $200 million “Big Data Research and Development 
Initiative”, one of whose main aims is to transform the use of big data 
for scientific discovery and biomedical research. 
The European Commission (EU) is not an exception and some 
projects have been proposed under the EU Research and Innovation 
Programme Horizon 2020. Other Health 2.0 initiatives are being carried 
out by different countries with the aim of accelerating innovation and 
obtaining better ways to manage patients, institutions and establish 
more convenient policies. Medical institutions, insurance companies 
and governments are applying healthcare Big Data to cut down medical 
service costs and to optimize patient’s attention.
Many initiatives gaze at or are focused on healthcare data 
digitalization. An Electronic Health Record (EHR) refers to the 
systematized collection of patient and population electronically stored 
health information in a digital format [4]. In 2005, only about 30% of 
office-based physicians and hospital in the US used EHR. By the end 
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of 2011, this figure rose to more than 50% for physicians and 75% for 
hospitals. We come back to the importance of EHR for healthcare below. 
The rest of the paper is structured as follows: First, we explore the 
relation between healthcare and economy. Next, we try to explain in 
more detail the opportunities offered by Big Data in the healthcare 
sector. We also comment on some challenges and risks. Big Data 
projects require a specific methodological approach commented in 
section V. Section VII present a hypothetical example based on real 
although non-public data from administrative records. Finally, we 
conclude and summarize.
II. Healthcare and the Economy
Health performance is positively correlated with economic 
performance; wealthier countries have healthier populations [5]. In 
many countries, the healthcare system has to afford several major 
challenges including ageing populations, chronic illnesses, ensuring 
universal access, guarantying equity and raising quality of care. New 
technologies and data analysis techniques might help to overcome 
these tasks. According to the Organisation for Economic Co-operation 
and Development (OECD) and due to the economic crisis, many years 
of consecutive health expending growth ground to a halt in 2008; 
health budgets were cut since then and, they are likely to remain tight 
for a number of years to come [6, 7]. On average, countries devote 
only 3% of their health budgets to spending on prevention [8]. The 
OECD recommends to policy makers focus their efforts on building 
health systems that meet population needs and deliver excellent value 
for money. Being able to reliably measure and compare health system 
performance will be crucial to achieve this goal. In this context, it is 
very important for governments and institutions to obtain timely data. It 
could help to ensure adequate and sustainable provision of high-quality 
services at correct administrative costs. In addition, it is necessary to 
study the occurrence and cost of fraud, abuse and corruption in health 
systems, as well as the policies to fight them. All these aims require 
new data, new statistics, better measures of outcomes and more 
patient-reported measures and it opens the door to the use of big data 
and suitable methods.
Health systems must adapt to take advantage of the development of 
new technologies to get personalized medicine. This paradigm tries to 
overcome the limitations of traditional medicine taking into account the 
unique genetic map for each individual. It is mandatory to effectively 
integrate new technologies into health systems to get personalized 
medicine and move to national aggregate measures of health care quality 
to more granular measures at hospitals [6, 7]. Healthcare information 
and advanced analytics may contribute to shift from population-based 
evidence for healthcare decision-making to the fusion of population 
and individual-based evidence in healthcare [9]. The effects might be 
immediate and cover from better treatments and diagnoses to reduce 
labor force transitions after a health/disability shock [10].
Focusing on the economic aspects of healthcare, we need to improve 
the state-of-the-art of forecasting models of health spending to develop 
expenditure projections that explore the impact of different policy 
scenarios and policies [11]. Some facts confirm this statement. The US 
has not seen an increase in life expectancy or last-days quality of life 
to match its huge outlay on health care. Although the US healthcare 
expenditures are the highest of any developed country, at 17,1% of 
GDP in 2014, according to the World Health Organization Global 
Health Expenditure database (http://data.worldbank.org/indicator/
SH.XPD.TOTL.ZS), such expenditures does not seem to improve 
health outcomes. However, the rising cost of medical care and health 
insurance is impacting the livelihood of many Americans [12].
Other countries have different problems. South Korea has one of 
the most advanced information technology (IT) infrastructures in the 
world. The application of IT in health systems is rapidly progressing 
from computerization to information, ubiquitous and start systems. All 
in all, the cost of health in terms of GDP is 7,4%, less than half the cost 
in of the US system. However, a major problem concerning healthcare 
resources lies in the regional disparities between medical services [13].
There are many researchers and institutions involved in the study of 
economic and health inequality [14]. Inequalities in health are linked 
to many factors, including differences in exposure to risk factors, and 
differences in the access to health care [15]. The economic crisis has 
had deep consequences in the labor market and public policies of many 
developed countries. Labor market conditions have deteriorated with 
increased unemployment rates and wage cuts, reforms in the public 
pension and the health care systems, among others. Undoubtedly, this 
may have an impact on the population’s health and/or the equity and 
efficiency of healthcare systems. Several authors provide evidence on 
the relationship among unemployment rates, business cycle conditions 
or housing conditions on health variables in the short-run [16, 17, 18]. 
Budget cuts have an impact on dependent people, for example and in 
Spain, demand for private long-term care insurance has grown in recent 
years and this can be attributed to budget cuts affecting the implementation 
of System of Autonomy and Attention to Dependent People [19].
Of course, we cannot ignore the potential that Big Data Technologies 
provide to pharmaceutical companies. In this sector spending is 
declining in real terms, due to top-selling drug patent losses and to 
fiscal consolidation measures adopted by many OECD countries. Using 
Big Data, pharmaceutical companies can better identify new potential 
drug candidates and develop new effective products, approving and 
reimbursing medicines more quickly [3].
III. Big Data Opportunities
Healthcare needs more efficient practices, research, and tools to 
harness the full benefits of personal health and healthcare-related 
data [20]. Many healthcare researches use advanced analytics tools to 
bring order, understanding data and reduce complexity. Researches, 
hospitals and physicians have access to rich sources of data that have 
potential for an increased understanding of disease mechanisms and 
better reporting. However, the size and complexity of the data present 
many challenges. There is a recognizable need for scalable tools that 
can discover patterns without discounting the statistical complexity of 
heterogeneous data or falling prey to the noise it includes [20]. This 
data-driven culture together with a share-knowledge attitude can play 
a critical role in the emergence of personalized healthcare. Numerous 
diseases have preventable risks factors or at least indicators of risk. 
Improving the prevention systems is possible and viable; we can 
consider not only healthcare or genomic variables, but also economic, 
demographic and lifestyle variables. Healthcare is moving from a 
disease-centered model towards a patient-centered model [21, 22]. Big 
Data technologies offer many opportunities to proactive medicine too. 
From the clinical patient’s data, it is possible to find similarities of that 
patient to millions of other patients. So, this allows physicians to go 
ahead and predict the likely of new relapses and the effect of drugs.
Getting into further detail, Big Data Analytics will impact healthcare 
in several ways [23, 24]:
• Right living: data can help patients to take an active role in their 
own health (i.e. practicing some sports).
• Right care: data can improve outcomes and reduce medical errors.
• Right provider: hospital and patients can select the best provider 
based on data.
• Right value: data analytics has potential to eliminate fraud, waste 
and abuse.
• Right innovation: a sharing-knowledge culture and data-driven 
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networks allow more flexible, efficient and innovative ways of 
working. 
• Providing patient centric services: provide faster relief by 
providing evidence-based medicine, reducing readmissions and 
reducing costs.
• Detecting spreading diseases earlier.
• Monitoring the hospital’s quality.
• Improving the treatment methods.
Frequently, Big Data and machine learning go together. Most of 
the challenges previously cited require a machine learning approach 
to obtain suitable models. Some applications can be found in [25]. 
Data from a variety of sources can be used to improve the accuracy 
of determining which chemical compounds would be effective drug 
treatments for a variety of diseases. Machine learning at scale has 
significant potential to boost drug discovery [26]. Some medical 
specializations like radiology need to deal with different formats like 
image or text, working with Big Data technologies, researchers can 
process together different data structures obtaining knowledge [27, 28].
A. Data Sources and Big Data
The majority of healthcare data are structured rather than semi-
structured or unstructured. On the one hand, data refers for relational 
database records, clinical notes, clinical images, statistical data, electronic 
healthcare records (EHR) and so on. On the other, researchers in the 
field of applied health economics often use survey data. For example, the 
Health and Lifestyle Survey (HALS) in Great Britain requires 1 hour face-
to-face interview plus several questionnaires (physiological + cognitive 
+ functional). In the 1984 – 1985 edition, only 53.7% on a sample of 
12,672 people provided a complete answer to the full questionnaires. In 
addition, researchers take into account other information from economic 
and demographic surveys, reporting socioeconomic status, household 
income, education, marital status, ethnic, children, ages, etc. These 
surveys provide aggregate instead of personal data [29].
On the contrary, Big Data analytics are frequently based on individual 
(anonymized) and dated data. This kind of data comes from ‘real’ and 
individual actions (usually administrative records), not from surveys. A 
real action can be a visit to a physician, a surgery, a treatment, a clinical 
checkup…. Although this data is also often aggregated due to privacy 
requirements, both in its individual or its aggregate forms, it offers 
more possibilities to researchers. Now, scientists do not completely 
depend on complex surveys designs, they have access to timely and 
relevant information based on individual records. This increase in data 
make easier to adopt the machine learning methodology. Moreover, 
access to sufficient data provide advantages as reduction of problems 
to obtain our training sample, more validation possibilities and datasets 
for additional testing. 
Many works evaluate lifestyle data in conjunction with health data, 
smoking, drinking and related behaviors that have a direct impact 
in health [30, 31]. The HALS is commonly used as primary dataset. 
This survey compiles questionnaire answers related to this subject. 
Around 10,000 individuals are interviewed each year with a low rate 
of complete responses. It is not trivial for surveys to take into account 
health and lifestyles models or health related behavior due to technical 
restrictions or attrition bias. With surveys, researchers cannot resample 
and obtain other values due to the required time to perform the survey 
and the technical complexity. Biased data is not an accurate reflection 
of reality. If data reflects biases, the obtained models can be wrong.
Surveys have also problems when researchers like to study the 
evolution over time of some variables. One problem is the frequency 
of the data. For some research questions it would be important to have 
daily data at hand but it is not usual in survey data, where it is common 
to employ monthly or annual data. However, data democratization 
is coming to help researchers all over the world to commit their 
objectives. For example, Banco Bilbao Vizcaya Argentaria bank 
(BBVA) is pioneering a new service generation providing anonymazed 
transaction data and offering forms of collaboration with research 
institutions and universities. Transaction data is a valuable information 
source including data about expenses using Point of Sale (PoS), 
pharmacies, gyms, etc. Again, this information can be completed by 
open data, including air quality, climatic parameters, etc. When we like 
to answer questions about public health arising from environmental 
problems, individual or aggregate health records can be complemented 
both with previous climatic variables and also with variables from 
smart cities (see, for instance, the decumanus project -http://www.
decumanus-fp7.eu/home/).
The need for semantically interoperable EHR is now a well-
established tenet [32, 33, 34]. Market mobility of the population (changes 
of residence, job changes, tourism) and its demand to have access to 
services of similar quality to those of their place of origin are factors that 
set in motion the creation of information systems based on interoperable 
EHR. For researchers, EHR implies the possibility of access to detailed 
information about individual patients, clinical histories, clinical notes, 
family histories, treatments and results, etc., in short, all the patient’s 
medical information. The spread of this standard remains difficult 
and challenging. The adoption of EHR implies a slow process. The 
integration if this kind of data with hospital information systems is a 
tough task. We consider that it is necessary to promote dissemination 
campaigns on the use of the standard to avoid errors and to make users 
aware of the importance of completing the requested information.
IV. Challenges and Risks
Despite the benefits of the Big Data, some resistances have to be 
solved [3]:
• Resistance to change: providers used to make treatment decisions 
independently using their own clinical judgment rather than 
protocols based on big data. However, Big Data technologies and 
algorithms are not intended to replace physicians, they just try to 
support the decision-making process. 
• Resistance to uncertain returns: many Big Data projects should be 
viewed from an experimental and research side. It not possible to 
determine in advance the accuracy of the developed algorithms. 
• Resistance to face new challenges related with privacy and deal 
with many players, technologies and data sources.
To solve these resistances, it is necessary to develop and spread talent 
transformation initiatives involving physician, managing positions and 
technical staff. The objective is to show the benefits linked to Big Data 
and, at the same time, to raise awareness of the risks associated with the 
management of expectation, privacy, security and technical challenges. 
Data anonymization is a mandatory step to comply with the current 
legislation [35]. The available of open health data for secondary use is 
fundamental for advance in the medical knowledge. The use of public 
datasets by researchers has effects on the acceleration of scientific 
advances as well as improvements in both the efficiency and efficacy 
of health processes [36]. A responsible use of individual’s data must be 
guaranteed, but it is possible to reconcile individual data privacy with 
socially valuable uses [37].
Many initiatives are trying to evolve the security and privacy 
standards. Some proposals come from sectors others than the healthcare 
system. For example, Blockchain systems were first developed for 
finance applications. Blockchain is paramount to realize the benefits 
of improved data integrity, decentralization and disintermediation 
of trust, and reduced transaction costs. It can offer a promising new 
distributed framework to amplify and support integration of health care 
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information across a range of uses and stakeholders. Blockchain relies 
on established cryptographic techniques to allow each participant in 
a network to interact without preexisting trust between the parties 
without in a model where there is not a central authority [38].
Clinical notes are a common piece of information in the daily 
routine of physicians, hospitals and laboratories. Understanding 
clinical notes in the right context is a great challenge. Clinical notes 
introduce mistakes, ungrammatical and short phrases, abbreviations, 
misspellings, semi-structured information, inconsistencies, which do 
not reflect all the information.
The state-of-the-art in text mining applications is evolving quickly 
and some successful use cases have been achieved. Watson from IBM, 
for instance, is able to understand questions and context, and to analyze 
through 200 millions pages of data and provide precise responses in 
seconds to physicians.
We can list in a non-exhaustive way a list of other technical 
challenges:
• Select risk factors [39]. Big data technologies and machine learning 
techniques made possible to obtain scalable models using large 
amount of data. 
• Patient similarity: researcher uses graphs theory and similarity 
measures to obtain patient similarity patters and improve the 
prevention system. For example, collaborative filtering methods 
allow us to leverage similarities across a large group of patient pool 
in real-time to deliver a personalized treatment (taking into account 
all available demographics and previous medical history). Using 
Big Data Science, we can generate predictions focused on other 
diseased that are based on data from similar patients.
• Medical Image Retrieval: analyzing huge image databases imply 
dealing with high dimensional and complex data. Dimensionality 
reduction techniques are useful to process this information. 
• Genetic data: Using genetic data for treatment optimization. Single 
human genome is about 3Gs. In order to get a complete genome the 
use of cloud technologies implies a cost around $5000.
• Public health: it is interesting to understanding disparities related 
to race, social condition, age, gender for epidemics or illnesses, 
using both clinical and socio-economic data.
V. Methodologies and models
Big Data and Data Science terms are strongly related. Data Science 
is about how to extract knowledge or insights from data in various 
forms, either structured or unstructured [40]. This scientific field 
implies the use of statistics, machine learning, data mining, predictive 
analytics, coding, etc. The Data Science process has been explained in 
[41] and is shown in the next figure.
Fig. 1. The Data Science Process [41].
Working with raw data involves spending time processing and 
cleaning data. The data acquisition phase requires up to 80% of the project 
time. Exploratory Data Analysis covers ways to summarize and visualize 
important characteristics of a data set. This step allows us to describe our 
data and generate hypotheses. After building our models (using machine 
learning or alternative algorithms) it is necessary to communicate the 
achieved results in an effective way. Finally, we can build a data product 
that adds value to companies, physicians and potential patients. As we 
can see in Figure 1, this is not a straightforward path.
Collecting, processing and cleaning data correctly (the data 
acquisition phase) are tough tasks. This is why is useful to standardize 
some steps in this phase. Figure 2 shows some recommended steps 
according many authors’ experience (and also ours).
Fig. 2. The data acquisition phase.
We can start selecting variables or data sources to collect and 
querying the data from a distributed file system, relational database 
management system or non-relational database. Next, cleaning data is 
a common task. Outliers need to be identified and treated properly. 
Data normalization allows us to seek for relations and compare results. 
Before automate the process, we need to test data in order to analyze 
whether variables and data source are useful and enough to accomplish 
our goals.
Researches in this area need to consider training and test set or, 
better, training, validation and test set if necessary for model selection 
using Big Data. We use the training set to discover relations and train 
the model. The validation set is used for tuning model parameters and, 
finally, the test set is used for performance evaluation. All these phases 
involve the use of some models, which normally must be specific to 
health-related variables. It is common in these cases to have counts 
(visits to physicians, episodes of illness, etc.), discrete variables 
(decisions made by physicians-patients, either in an agency-principal 
model or in any other context), data reflecting dynamics (duration 
of an illness-episode, duration of a treatment, etc.) and many other. 
Dealing with these specific data requires specific methods when we try 
to extract causal relationships. All these issues are of course out of the 
scope of this paper.
VI. An EmpiricalExample
This section is devoted to describe an example of the use of Big 
Data and Big Data methods applied to a specific health problem, which 
also involves economic issues. Data could be in a repository and it 
could correspond to administrative records of a health institution (a 
hospital, a diagnosis center, etc.). The availability of such a repository 
containing medical diagnoses could allow doing some analysis based 
on the text introduced by the practitioners. Let us assume, for instance, 
that we have a large database containing image-diagnostic reports 
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(we assume a sufficiently large sample size to avoid problems of non-
representativeness). In these cases, we usually have data concerning 
patient ID, radiologist ID, hospital, section, date / time of the clinical 
test, date / time of the diagnosis, room in which the test has been 
performed, type of test (X-ray, CT, ultrasound, magnetic resonance, 
etc.). In addition, records usually contain a comment written by the 
physician who ordered the imaging test. The information is normally 
completed with patient-related data such as birthdate, address, 
birthplace, sex and, finally, some material with clinical diagnoses.
A problem of interest faced in reality and developed in some 
research papers may be to automatically recognize medical diagnoses 
that report an allergic reaction to the contrast provided to make the test. 
In this way, it is possible to compare incidence rates between different 
hospitals to test if there is any effect of the procedures used at the 
different units or even if any effect arising from clinical materials of 
the different suppliers could be identified. This question is not trivial 
because, in some cases, the doctor will note that the patient “reports 
that he has previously suffered an allergic reaction or is allergic to 
contrast”. On the other hand, if the patient suffers an allergic reaction, 
the doctor should write it indicating the necessity (or not) to provide 
any treatment.
A classic and standard approach to address this type of problem 
consists in selecting a broad sample where researchers manually label 
reports with and without allergic reaction occurred during the test (of 
course, researchers must read and interpret the recorded text). Therefore 
and for this exercise, we only need the clinical diagnosis issued by 
the practitioner, in a raw text format that must be vectorized prior to 
the elimination of stop-words. This just constitutes a classification 
problem. The goal is to obtain an algorithm that allows detecting the 
occasions where the patient has suffered an allergic reaction during the 
test. The original sample is separated into training and checking sets. 
We use a very simple example of the potential of some approaches 
based on previous works by the authors using text containing Spanish 
language. We can report some conclusions from empirical evidence 
obtained: when the text contains the words (in Spanish) “alérgica” and 
“refiere” there is a 97% probability that the doctor refers to a previous 
problem with the contrast or he is reporting the patient is contrast-
allergic. On the contrary, if only the word “alérgica” appears, there is a 
high probability that an allergic episode is being reported.
Classification algorithms can be used jointly with association rules. 
Association rules algorithms allow us to obtain the relevant item sets 
(those ones with support values close to or higher than the chosen 
reference). In this context, an item set is a bag of words indicating 
common word association in radiology reports. Furthermore, rules 
allow us to find associations between words. For example, in our 
dataset we have found that if the report contains the (Spanish) words 
“conclusión” and “compara” it is highly likely (+96%) the appearance 
of the word “previo”. This association computed for a real problem 
is presented in Figure 3. A very simple conclusion can be inferred: 
radiologists are frequently studying the progress of diseases and they 
need to compare different tests performed on different dates. But also, 
radiologists can associate different histories attending common socio-
demographic variables in a way such patients can benefit from better 
reports. Even using very simple examples, we hope the reader can 
realize the potential of these techniques using a huge dataset for saving 
time and costs.
How can these methods help to reduce cost or to advance in 
individual diagnosis (personalized medicine)? Text vectorization 
also makes it possible to analyze the most similar diagnoses (using 
similarity measures) to a given one. In this way and, after receiving 
a new clinical diagnosis, it is possible to find similar diagnoses in the 
historical to check if there is a relationship between patients already 
treated and the new one. If this relationship exists, as pointed out in 
previous paragraphs of this paper, the patient can be given a better 
preventive service based on the evolution of similar cases. Finally, this 
same technique also allows the execution of topic modeling algorithms 
that permit grouping documents into different topics. This is useful 
for launching new research hypotheses based on documents that are 
grouped in an unexpected way. Classification algorithms can also help 
to infer associations among clinical terms in relationships sometimes 
unknown. They also can help association among patients who share 
similar demographics with benefits for the quality of the diagnosis 
and treatments. All in all, the health services can avoid in many cases 
spending because of trial-error in the treatments to new patients and, in 
many other cases, they can shorten the duration of the treatment when 
the historical information results in an adequate treatment for the new 
patients. In both cases, the health institutions can get important budget 
cuts and they can also optimize the quality of the of the care provided.
Fig. 3. Example of association rules
VII. Conclusions
Any economy depends on using data. Data is everywhere, in every 
sector, in every institution, in every country. The potential value that 
can be extracted from data in the healthcare sector is considerable 
and promising. Big Data offers many opportunities but there are some 
associated risks too. To ensure patient’s privacy is paramount. Solving 
privacy frontiers will allow researchers to share data and accelerate 
the availability of results. Researchers need to consider Data Science 
methodologies to be able to successfully deal with huge amount of data.
The current state of public finances in many countries could help 
decision-makers in adopting some measures or policies concerning the 
use of all available information in a more effective and efficient ways 
to reduce both costs of administration and production in the healthcare 
sector. Each day the users of public or private institutions providing 
health services produce thousands of administrative records, which can 
be used by analysts and researchers to inform the policies as a way of 
ex – ante or ex – post evaluation of them. Here is where Big Data and 
Big Data technologies have opportunities and challenges, but also risks.
The collaboration of public and private institutions with experts 
and researchers in various fields (privacy, anonymization, machine 
learning...) is required, when we like to take full advantage provided 
by Big Data and Big Data technologies. All agents must work together 
transparently. In addition, it is necessary to inform and train all those 
involved effectively.
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